1-Day-Price-Prediction
-0.8%
1-Week Prediction
-1.73%
1-Month Prediction
-1.56%
2026 Prediction
+74.56%
2030 Prediction
+347.7%
Based on our advanced algorithm, we predict that RARE stock price will experience significant movement in the coming periods. Our 1-day prediction estimates a price of $22.93, while the 1-week outlook suggests a value of $22.71. For the 1-month forecast, we project a price of $22.75. Looking further ahead, our 2026 projection estimates a value of $40.34, with a long-term 2030 forecast reaching $103.46. Stay informed and make strategic decisions with our data-driven insights!
Should I Buy Ultragenyx Pharmaceutical Inc Stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. RARE has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
RARE stock price ended at $22.54 on Tuesday, after losing -2.47%
The Ultragenyx Pharmaceutical Inc stock price decreased by -2.47% on the last trading day (06 Jan 2026), dropping from 23.115 to 22.54. Throughout the last trading session, the stock experienced a fluctuation of 4.71% , ranging from a day low of $22.075 to a day high of 23.115. The price has declined in 5 of the last 10 days, resulting in a total change of -32.72% during this period. On the last day, trading volume increase by -215.45K shares, with the falling prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 3.74M shares were traded, amounting to approximately 84.20M.
RARE Technical Signals
RARE(Ultragenyx Pharmaceutical Inc Corp) has 2 buy signals and 4 sell signals now. The current trend is a downtrend starting from 2026-01-02. The total price change during this trend is -4.51%. Recently, the price has dropped while volume droped, indicating a potential rebound signal. The average turnover of RARE over the last 5 trading days is 119.42M. Overall, the technical indicator signals lean more toward a Bearish outlook in the mid-term.
RARE Moving Average Analysis
Ultragenyx Pharmaceutical Inc's overall moving average trend leans more bearish as of Tuesday, January 6, 2026, with 4 negative signals and 0 positive signal. In the mid-term, the SMA_20 being below the SMA_60 signals a strong bearish trend. There will be some resistance from the lines at $37.25, and $43.63. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $16.60, and $10.22. A break-down below any of these levels will issue sell signals.
RARE Short Selling Analysis
The short sale ratio of Ultragenyx Pharmaceutical Inc(RARE) as of 10 Dec 2025 is 17.60%, rising from last trading day. With increasing price from 36.30 to 36.00. The short sell activity indicate that short sellers may be anticipating further declines.
Technical Signal
Technical Signals Summary
Sell
4
Buy
2
Moving Average
Swing
NegativeStock Price Below SMA_5
Short Term
NegativeSMA_5 Below SMA_20
Mid Term
NegativeSMA_20 Below SMA_60
Long Term
NegativeSMA_60 Below SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
2 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
4 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
RARE Stock Forecast
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
In 2026, Ultragenyx Pharmaceutical Inc (RARE) is anticipated to change hands in a trading channel between $34.14 and $58.73.
Ultragenyx Pharmaceutical Inc Stock Forecast 2026
Jan 2026: RARE Stock Forecast
Potential ROI: 17.44%
In Jan 2026, Ultragenyx Pharmaceutical Inc's value is forecasted to reach an average price of $40.34. The price is predicted to fluctuate between a low of $35.99 and a high of $47.58.
Feb 2026: RARE Stock Forecast
Potential ROI: 42.51%
In Feb 2026, Ultragenyx Pharmaceutical Inc's value is forecasted to reach an average price of $48.95. The price is predicted to fluctuate between a low of $42.22 and a high of $56.96.
Mar 2026: RARE Stock Forecast
Potential ROI: 15.93%
In Mar 2026, Ultragenyx Pharmaceutical Inc's value is forecasted to reach an average price of $39.82. The price is predicted to fluctuate between a low of $34.50 and a high of $42.84.
Apr 2026: RARE Stock Forecast
Potential ROI: 50.63%
In Apr 2026, Ultragenyx Pharmaceutical Inc's value is forecasted to reach an average price of $51.74. The price is predicted to fluctuate between a low of $51.68 and a high of $58.73.
May 2026: RARE Stock Forecast
Potential ROI: 46.78%
In May 2026, Ultragenyx Pharmaceutical Inc's value is forecasted to reach an average price of $50.42. The price is predicted to fluctuate between a low of $40.42 and a high of $58.33.
Jun 2026: RARE Stock Forecast
Potential ROI: 24.89%
In Jun 2026, Ultragenyx Pharmaceutical Inc's value is forecasted to reach an average price of $42.90. The price is predicted to fluctuate between a low of $34.14 and a high of $50.25.
Jul 2026: RARE Stock Forecast
Potential ROI: 50.63%
In Jul 2026, Ultragenyx Pharmaceutical Inc's value is forecasted to reach an average price of $51.74. The price is predicted to fluctuate between a low of $47.44 and a high of $57.99.
Aug 2026: RARE Stock Forecast
Potential ROI: 49.56%
In Aug 2026, Ultragenyx Pharmaceutical Inc's value is forecasted to reach an average price of $51.38. The price is predicted to fluctuate between a low of $48.46 and a high of $55.27.
Sep 2026: RARE Stock Forecast
Potential ROI: 21.68%
In Sep 2026, Ultragenyx Pharmaceutical Inc's value is forecasted to reach an average price of $41.80. The price is predicted to fluctuate between a low of $37.62 and a high of $47.67.
Oct 2026: RARE Stock Forecast
Potential ROI: 50.63%
In Oct 2026, Ultragenyx Pharmaceutical Inc's value is forecasted to reach an average price of $51.74. The price is predicted to fluctuate between a low of $43.78 and a high of $56.68.
Nov 2026: RARE Stock Forecast
Potential ROI: 50.63%
In Nov 2026, Ultragenyx Pharmaceutical Inc's value is forecasted to reach an average price of $51.74. The price is predicted to fluctuate between a low of $50.96 and a high of $51.97.
Dec 2026: RARE Stock Forecast
Potential ROI: 44.78%
In Dec 2026, Ultragenyx Pharmaceutical Inc's value is forecasted to reach an average price of $49.73. The price is predicted to fluctuate between a low of $49.40 and a high of $52.29.
RARE Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to Ultragenyx Pharmaceutical Inc(RARE), our algorithm predicts RARE's 1-month price at $23.91, with an 1.33%upwardshift. Using a similarity score up to 97.92%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Ultragenyx Pharmaceutical Inc (RARE.O) stock, as of Sunday, January 4, 2026 , forecasts a 1.33% change over the next month, based on its high correlation with BKNG.O stock patterns. The similarity between their price movements over the analyzed periods is 97.92%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
RARE
No data
BKNG
Up: 1.33%Similarity: 97.92%
RARE Seasonality Analysis
Based on RARE's historical stock price data across all years, the probability of a positive return in January is63.64%, suggesting it maybe an ideal month to invest in RARE. In contrast,Juneoffers the highest probability of positive returns at70.00%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Ultragenyx Pharmaceutical Inc (RARE.O) stock in June has the highest probability of a positive return (70.00%), while September has the lowest probability (20.00%).
Performance Seasonality
The chart shows Ultragenyx Pharmaceutical Inc. (RARE)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
People Also Watch
AVGO
Broadcom Inc
343.77USD
0.10%
AAPL
Apple Inc
262.36USD
-1.83%
NVDA
NVIDIA Corp
187.24USD
-0.47%
AMZN
Amazon.com Inc
240.93USD
3.38%
WMT
Walmart Inc
114.34USD
1.45%
MSFT
Microsoft Corp
478.51USD
1.20%
META
Meta Platforms Inc
660.62USD
0.28%
GOOG
Alphabet Inc
314.55USD
-0.87%
TSLA
Tesla Inc
432.96USD
-4.14%
GOOGL
Alphabet Inc
314.34USD
-0.70%
Frequently Asked Questions
Should I buy Ultragenyx Pharmaceutical Inc (RARE.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. RARE has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
Which months have the highest win rate for buying Ultragenyx Pharmaceutical Inc (RARE.O) stock in a year?
The radar chart shows that buying Ultragenyx Pharmaceutical Inc (RARE.O) stock in June has the highest probability of a positive return (70.00%), while September has the lowest probability (20.00%).
How has Ultragenyx Pharmaceutical Inc. (RARE)'s stock price performed over the past three years?
RARE's stock price fell by -12.66% in 2024,decreased by -44.11% in 2025, and went down by 4.49%in 2026.
Which bullish technical signals does RARE have?
Bullish technical signals of RARE include: RSI_14 < 30, CCI_20_0.015 < -100.
Which bearish technical signals does RARE have?
Bearish technical signals of RARE include: AO_5_34 < 0, MOM_10 < 0, MACD_12_26_9 < 0, Price crosses below 5-day SMA.
Is RARE a buy based on overall technical signals summary?
RARE has 2 buy signals and 4 sell signals now. Overall the technical rating for RARE is Sell . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of RARE.
What is the trend of Ultragenyx Pharmaceutical Inc (RARE)'s moving average?
Ultragenyx Pharmaceutical Inc's overall moving average trend leans more bearish as of January 06 2026, with 4 negative signals and 0 positive signal.
What is price prediction for RARE stock next month?
The price prediction chart for Ultragenyx Pharmaceutical Inc (RARE.O) stock, as of January 04 2026, forecasts a 1.33% change over the next month, based on its high correlation with BKNG stock patterns. The similarity between their price movements over the analyzed periods is 97.92%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2026 for Ultragenyx Pharmaceutical Inc (RARE) Stock?
In Dec 2026, Ultragenyx Pharmaceutical Inc's value is forecasted to reach an average price of $49.73. The price is predicted to fluctuate between a low of $49.40 and a high of $52.29.
What is price prediction 2030 for Ultragenyx Pharmaceutical Inc (RARE) Stock?
In Dec 2030, Ultragenyx Pharmaceutical Inc's value is forecasted to reach an average price of $102.45. The price is predicted to fluctuate between a low of $82.35 and a high of $126.92.